Announcement of the consolidated Results of Remote E-Voting and E-Voting during Twenty Sixth
Annual General Meeting of Cadila Healthcare Limited
Pursuant to the provisions of section 108 and 109 of the Companies Act, 2013 ("the Act") read with rule 20 of the Companies (Management and Administration) Rules, 2014 ("the Rules"), Cadila Healthcare Limited ("the Company") had provided remote e-voting facility to the members for exercising the voting rights and e-voting facility was also provided during the Twenty Sixth Annual General Meeting ("AGM") of the Company.
The voting on the 7 resolutions contained in the Notice of AGM dated July 9, 2021 were casted through remote e-voting and e-voting during AGM. Based on the report submitted by Mr. Manoj Hurkat, Practicing Company Secretary, the Scrutinizer appointed for both, remote e-voting and e-voting during AGM, I declare the 7 resolutions contained in the Notice of AGM as passed with requisite majority. The summary of results is as under:
Item No. of Notice
Particulars of business
Voting in favour of
Votes
against
the
the resolution
resolution
Nos.
%
Nos.
%
Item No. 1 of the Notice (As
Remote e-voting
911609559
100
479
Negligible
an Ordinary Business)
E-voting during AGM
7167
100
0
0
Total
911616726
100
479
Negligible
Item No. 2 of the Notice (As
Remote e-voting
911633134
100
5018
Negligible
an Ordinary Business)
E-voting during AGM
7167
100
0
0
Total
911640301
100
5018
Negligible
Item No. 3 of the Notice (As
Remote e-voting
874786028
98.52
13104966
1.48
an Ordinary Business)
E-voting during AGM
7072
98.67
95
1.33
Total
874793100
98.52
13105061
1.48
Item No. 4 of the Notice (As
Remote e-voting
911633950
100
2935
Negligible
a Special Business)
E-voting during AGM
7167
100
0
0
Total
911641117
100
2935
Negligible
Item No. 5 of the Notice (As
Remote e-voting
815069411
96.90
26051286
3.10
a Special Business)
E-voting during AGM
7072
98.67
95
1.33
Total
815076483
96.90
26051381
3.10
Item No. 6 of the Notice (As
Remote e-voting
887348742
99.94
542380
0.06
a Special Business)
E-voting during AGM
7167
100
0
0
Total
887355909
99.94
542380
0.06
Item No. 7 of the Notice (As
Remote e-voting
864063296
97.23
24587390
2.77
a Special Business)
E-voting during AGM
7167
100
0
0
Total
864070463
97.23
24587390
2.77
For, CADILA HEALTHCARE LIMITED
PANKAJ RAMANBHAI PATEL
Digitally signed by PANKAJ RAMANBHAI PATEL Date: 2021.08.11 18:46:24 +05'30'
Cadila Healthcare Limited published this content on 11 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2021 16:05:03 UTC.
Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.